Phase 4 Chronic Hepatitis Clinical Trials
9 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–9 of 9 trials
Recruiting
Phase 4
ASC22 Combined With Peg-IFNa in Achieving Functional Cure in Patients With Chronic Hepatitis B Virus Infection
Chronic Hepatitis B
The Second Affiliated Hospital of Chongqing Medical University150 enrolled1 locationNCT07573943
Recruiting
Phase 4
SGLT2i to Prevent of Liver Complications in Patients With CHB and Diabetes Mellitus
Chronic Hepatitis B
Chinese University of Hong Kong412 enrolled1 locationNCT06364930
Recruiting
Phase 4
Study of Tenofovir Alafenamide in HBV-Infected Pregnant Women
Chronic Hepatitis BTenofovir Alafenamide Fumarate
First People's Hospital of Hangzhou50 enrolled1 locationNCT05853718
Recruiting
Phase 4
Cessation of Long Term NAs vs. Keeping on NAs Among CHB Patients (CNAVK)
Chronic Hepatitis B
Humanity & Health Medical Group Limited2,000 enrolled1 locationNCT03792919
Recruiting
Phase 4
Efficacy and Safety of Antiviral Therapy With Peg-interferon for Chronic Hepatitis B Complicated With Nonalcoholic Fatty Liver Disease（OCEAN PROJECT）
Chronic Hepatitis BNonalcoholic Fatty Liver Disease
First Affiliated Hospital of Wenzhou Medical University1,500 enrolled5 locationsNCT06368882
Recruiting
Phase 4
The Evaluation of efficacy and safety of Tenofovir in combination with peginterferon alpha-2a subcutaneous for 48 weeks in patients with chronic hepatitis B viral infections (HBV)
Chronic Hepatitis B viral infection
Dr Anouk Dev75 enrolled1 locationACTRN12610001101077
Recruiting
Phase 4
A single-arm, open-label, pilot study evaluating the efficacy and safety of directly observed peginterferon alfa-2a with ribavirin in conjunction with a peer counsellor in patients actively using injecting drugs who have chronic hepatitis C and attend a drug and alcohol centre.
Chronic hepatitis C virus (HCV) infection.Side effects related to chronic Hepatitis C virus (HCV) infection and treatment in active injecting drug users (IDUs).Factors affecting compliance of active injecting drug users (IDUs) for standard pharmacotherapy treatment of chronic Hepatitis C virus (HCV) infection.+1 more
Dr Joe Sasadeusz50 enrolled1 locationACTRN12608000400369
Recruiting
Phase 4
The Extension Study
Chronic Hepatitis B Virus Infection
Prof. Meng Ngu, Concord Hospital28 enrolled1 locationACTRN12606000283572
Completed
Phase 4
The Chariot Study
Chronic Hepatitis C genotype 1
Roche Products Pty Ltd816 enrolled1 locationACTRN12605000488606